LOCALLY-ADVANCED NON-SMALL CELL LUNG CANCER
Clinical trials for LOCALLY-ADVANCED NON-SMALL CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new LOCALLY-ADVANCED NON-SMALL CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for LOCALLY-ADVANCED NON-SMALL CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo targets lung cancer without chemo or surgery
Disease control Recruiting nowThis study tests a drug called NBTXR3 given with radiation therapy for people with locally-advanced non-small cell lung cancer who cannot have chemotherapy or surgery. The goal is to see if the combination is safe and helps control the cancer. About 40 adults will take part in th…
Matched conditions: LOCALLY-ADVANCED NON-SMALL CELL LUNG CANCER
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 07:45 UTC
-
Smart radiation tailored to each tumor could extend lung cancer survival
Disease control Recruiting nowThis study tests a new way to give radiation therapy for stage III lung cancer that cannot be removed by surgery. The treatment is personalized based on how sensitive each person's tumor is to radiation. The goal is to see if this approach helps people live longer and keeps the c…
Matched conditions: LOCALLY-ADVANCED NON-SMALL CELL LUNG CANCER
Phase: NA • Sponsor: Capital Medical University • Aim: Disease control
Last updated May 26, 2026 07:23 UTC
-
New combo therapy aims to shrink advanced lung cancer and enable surgery
Disease control Recruiting nowThis study tests a new approach for people with advanced non-small cell lung cancer that has spread to lymph nodes on the opposite side of the chest. Participants will receive targeted radiation, immunotherapy, and chemotherapy before surgery to see if the cancer can be reduced e…
Matched conditions: LOCALLY-ADVANCED NON-SMALL CELL LUNG CANCER
Phase: PHASE2 • Sponsor: Yang Hong • Aim: Disease control
Last updated May 20, 2026 11:53 UTC
-
Could less be more? new study tests lower cancer drug doses to cut side effects
Disease control Recruiting nowThis study tests whether giving a lower, less frequent dose of the cancer drug atezolizumab can still control tumors while causing fewer side effects. About 30 adults with advanced lung, liver, skin, or sarcoma cancers will receive the drug alone or with other treatments. Researc…
Matched conditions: LOCALLY-ADVANCED NON-SMALL CELL LUNG CANCER
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 18, 2026 12:13 UTC